-
MEK1/2–c-Myc Cooperation Controls TERT in hESCs
2026-09-05
This study identifies a cooperative MEK1/2–c-Myc:MAX mechanism that maintains TERT transcription in human embryonic stem cells by limiting polycomb-associated repression. Its chromatin and transcriptional evidence links MAPK signaling to telomere-maintenance gene regulation and provides a framework for interpreting c-Myc pathway perturbation in pluripotent stem-cell models.
-
IR-1061 Near Infrared Fluorescent Dye Workflow
2026-09-05
IR-1061 combines strong OTN-NIR fluorescence with low-background deep-tissue imaging potential, but its hydrophobicity makes formulation design central to assay performance. This practical guide connects solvent handling, polymer encapsulation, quality control, imaging setup, and troubleshooting to the reference study’s findings on PLA microenvironments.
-
Machine Learning for Senolytic Discovery
2026-09-04
The reference study shows that machine-learning models trained only on published screening data can identify senolytic candidates despite limited and heterogeneous datasets. Computational prioritization followed by human-cell validation produced three active compounds—ginkgetin, periplocin, and oleandrin—while substantially reducing early discovery costs.
-
Etoposide Nanoparticles for Local Brain Tumor Delivery
2026-09-04
The reference study developed a sprayable pectin hydrogel containing PLA–PEG-coated etoposide and olaparib nanocrystals for local administration to brain tissue after tumor resection. Its findings support formulation stability, sprayability, brain adhesion, sustained release, and tissue distribution, while remaining preclinical and not yet demonstrating therapeutic efficacy in an intracranial tumor model.
-
Cy5-UTP for RNA Probe Synthesis and FISH
2026-09-03
Cy5-UTP enables direct, far-red visualization of RNA made by T7 in vitro transcription, reducing dependence on post-labeling stains. Its strongest use cases include FISH, dual-color expression arrays, RNA trafficking studies, and process QC for emerging circular RNA workflows.
-
Prochlorperazine: Applied Research Workflow
2026-09-03
Prochlorperazine combines dopamine D2 receptor antagonism with experimentally useful effects on melanoma phenotypes and membrane trafficking. This workflow shows how to build concentration-response, wound-healing, and endocytosis studies while controlling solvent, timing, cytotoxicity, and phenotype-specific confounders.
-
Dehydroepiandrosterone (DHEA) Research Workflows
2026-09-02
Build better ovarian inflammation, neural stem-cell, and neuroprotection experiments with DHEA by separating disease-induction exposure from protective-dose testing. This workflow connects CD163-positive macrophage biology with granulosa-cell apoptosis while addressing solubility, vehicle, timing, and assay-design risks.
-
KG-501 Workflow for CREB–TLR4 Assays
2026-09-02
KG-501 enables a practical test of whether CREB–coactivator signaling contributes to macrophage polarization, inflammatory transcription, or cancer-cell growth. This workflow connects the compound’s KIX-domain mechanism with the TLR4-centered colitis-associated colorectal cancer model while clearly separating published findings from recommended assay conditions.
-
Anlotinib Hydrochloride: Assay Design Guide
2026-09-01
Anlotinib hydrochloride is a multi-target tyrosine kinase inhibitor whose value in cancer research depends on more than receptor potency alone. This guide translates its VEGFR2, PDGFRβ, FGFR1, and ERK activity into a practical, orthogonal assay strategy for interpreting anti-angiogenic results.
-
Novobiocin, DNA Replication, and E. faecalis Protoplasts
2026-09-01
A study in Enterococcus faecalis protoplasts shows that novobiocin-mediated inhibition of DNA replication is accompanied by reduced cell enlargement and blocked vacuole formation. The work provides a time-resolved framework for linking chromosome replication with membrane expansion and vacuolar remodeling in wall-deficient bacterial cells.
-
Acetylspiramycin for Resistance Research
2026-08-31
Acetylspiramycin, or Spiramycin B, is a 16-membered macrolide comparator for studying ribosomal inhibition when conventional macrolides lose activity. This guide translates recent Mycoplasma pneumoniae resistance findings into practical broth microdilution, resistance-genotyping, and host-response workflows.
-
Ciclesonide Workflows for Respiratory Research
2026-08-30
Ciclesonide supports mechanism-aware respiratory assays that separate prodrug activation from glucocorticoid receptor potency. This guide translates its bronchial-cell and airway-model performance into practical workflows while clarifying why recent ERAD degrader findings involving desonide should be treated as a related but distinct research direction.
-
Chemotherapy Enhances Neoantigen T Cell Therapy
2026-08-29
Sagie et al. identify the KRAS.G12V-specific TCR T104 and show that lymphodepleting chemotherapy can improve neoantigen presentation through immunoproteasome activation and increased HLA-I surface expression. The study provides a mechanistic rationale for combining chemotherapy with TCR-T cells, tumor-infiltrating lymphocytes, or T cell engagers while emphasizing the need to optimize treatment regimens.
-
Fenipentol: Workflow for GI and Liver Research
2026-08-29
Fenipentol supports controlled studies of estrogen receptor α signaling, hepatobiliary secretion, and gastrointestinal physiology without the compositional variability of a botanical extract. This practical workflow also shows how to use the 1-phenyl-2-pentanol fibrosis study as a design reference while keeping the two positional isomers scientifically distinct.
-
GDC-0941 PI3K Inhibitor Workflow Guide
2026-08-28
Build reproducible PI3K/Akt pathway inhibition experiments with GDC-0941 across signaling, viability, apoptosis, resistance, and xenograft workflows. This guide connects target-engagement measurements with the DRD4–Akt–β-catenin biology of liver cancer stem cells while clearly separating validated findings from practical assay recommendations.